1. AB0552 Relative efficacy and tolerability of intravenous and subcutaneous abatacept compared with tumor necrosis factor inhibitors in rheumatoid arthritis patients with an inadequate response to conventional disease-modifying antirheumatic drugs. (23rd January 2014) Authors: Hochberg, M.; Berry, S.; Broglio, K.; Nadkarni, A.; Rosenblatt, L.; Trivedi, D.; Hebden, T. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 670 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. SAT0233 Comparison of Abatacept and Other Biologic DMARDS for the Treatment of Rheumatoid Arthritis Patients: A Systematic Literature Review and Network Meta-Analysis. (10th June 2014) Authors: Hochberg, M.; Janssen, K.; Broglio, K.; Walsem, A.V.; Nadkarni, A. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 676 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗